Back to Search Start Over

Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant.

Authors :
Takemori W
Yamamura K
Tomita Y
Egami N
Eguchi K
Nagata H
Shirouzu H
Ishikawa Y
Nakajima D
Yoshizawa A
Date H
Ohga S
Source :
Pediatric pulmonology [Pediatr Pulmonol] 2022 May; Vol. 57 (5), pp. 1366-1369. Date of Electronic Publication: 2022 Mar 17.
Publication Year :
2022

Abstract

Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) cause progressive PH on the distinct genetic impact. A 29-month-old boy presented with a loss of consciousness. He had severe PH refractory to pulmonary vasodilators. Hypoxemia and ground-glass opacity on the chest computed tomography were present, and significant pulmonary edema developed after the introduction of continuous intravenous prostaglandin I <subscript>2</subscript> . Based on the clinical diagnosis of PVOD, he underwent a single living-donor lobar lung transplantation with the right lower lobe of his mother. The pathological findings of his explanted lung showed intimal thickening and luminal narrowing of the pulmonary vein. A genetic test revealed a novel heterozygous splice acceptor variant (c.77-2A>C) in BMPR2, which is typically associated with I/HPAH. This is the first pediatric case of PVOD with BMPR2 variant, supporting the concept that I/HPAH and PVOD are part of a spectrum of pulmonary vascular disease.<br /> (© 2022 Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1099-0496
Volume :
57
Issue :
5
Database :
MEDLINE
Journal :
Pediatric pulmonology
Publication Type :
Editorial & Opinion
Accession number :
35229499
Full Text :
https://doi.org/10.1002/ppul.25877